Orion Group Holdings, Inc. ORN

PMS is a severely disabling genetic disorder related to autismU.S. prevalence is estimated at approximately 1 in 7,300 people HOPE-2 is partially funded through Oryzon’s VANDAM project under Med4Cure, an Important Project of Common European Interest (IPCEI) on HealthThe study is being advanced in collaboration with the Spanish Phelan–McDermid Syndrome Association MADRID and CAMBRIDGE, Mass., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage

HOUSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company” or “Orion”), a leading specialty construction company, today announced that management will participate in the 25th Annual D.A. Davidson Diversified Industrials & Services Conference on September 24 in Nashville, TN. About Orion Group Holdings Orion Group Holdings, Inc., a leading specialty construction company serving the infrastructure, industrial and building sectors, provides services both on an

MADRID and CAMBRIDGE, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that its management will participate at the following upcoming events: HC Wainwright 28th Annual Global Investment Conference 2026, September 14-16Location: Lotte New York Palace Hotel, New York, United StatesPresentation date and time: September 15, 10:30 am ET European Main MidCap Event

Iadademstat is under clinical development in acute myeloid leukemia (AML), including in combination with gilteritinib in the Phase Ib FRIDA trial in patients with FLT3-mutated relapsed/refractory (R/R) AML FRIDA data presented at EHA-2026 showed a high composite complete remission (CRc) rate of 67% in heavily pretreated FLT3-mutated R/R AML patients, together with a favorable safety profile MADRID and CAMBRIDGE, Mass., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733

Despite a GAAP loss, Orion Group Holdings Inc (ORN) reports robust revenue growth and a thriving concrete business, while adjusting guidance to reflect marine segment delays.

ORN stock dips after Q2 earnings miss estimates as Marine project delays cut volumes, margins and guidance despite strong Concrete growth.

Moby summary of Orion Group Holdings, Inc.'s Q2 2026 earnings call

Although the revenue and EPS for Orion Marine (ORN) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

HOUSTON, July 28, 2026 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company” or “Orion”), a leading specialty construction company, today reported its financial results for the second quarter ended June 30, 2026, and updated its full-year 2026 outlook. Highlights for the quarter ended June 30, 2026 Revenue of $221.9 million, GAAP net loss of $4.1 million, or $0.10 per diluted share, Adjusted EBITDA of $7.9 million and Adjusted EPS of $0.02 per diluted shareBooked awards and c

Positive clinical data presented at EHA for iadademstat in first line acute myeloid leukemia (AML); iadademstat+azacitidine+venetoclax resulted in 100% ORR, 89% CRc and 78% CR, including in patients with TP53 or RAS mutations; the triplet continued to demonstrate a favorable safety profileIn FLT3-mutated refractory-relapsed patients, iadademstat with gilteritinib continued to show a favorable safety profile and a high CRc rate of 67%Enrollment initiated in Phase II trial of iadademstat in essent

Conference Call to be held Wednesday, July 29, 2026, at 8:00 a.m. Central TimeHOUSTON, July 14, 2026 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN), a leading specialty construction company, today announced that it will issue its second quarter 2026 financial results after the close of the stock market on Tuesday, July 28, 2026. A conference call and audio webcast with analysts and investors will be held the next day, Wednesday, July 29, 2026, at 9:00 a.m. Eastern Time/8:00 a.m. Cent